Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert Pang

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
American Journal of Epidemiology|November 3, 2016
Direct Participation in and Indirect Exposure to the Occupy Central Movement and Depressive Symptoms: A Longitudinal Study of Hong Kong AdultsMichael Y Ni, Tom K Li, Herbert Pang, et al.
Journal of Hepatology|October 16, 2012
IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patientsMelanie E Garrett, Manal F Abdelmalek, Allison Ashley-Koch, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Genetic predisposition to lung adenocarcinoma among never-smoking Chinese with different epidermal growth factor receptor mutation statusLi Han, Cheuk-Kwong Lee, Herbert Pang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 1, 2012
Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206Michael J Kelley, Jeffrey A Bogart, Lydia D Hodgson, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2020
Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancerXiaowen Cao, Apar Kishor Ganti, Thomas Stinchcombe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 30, 2013
A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904Joseph K Salama, Lydia Hodgson, Herbert Pang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307Sarita Dubey, Pasi A Jänne, Lee Krug, et al.
Molecular Cancer Therapeutics|July 13, 2018
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105Yingmiao Liu, Mark D Starr, John C Brady, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 2015
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groupsXiaofei Wang, Lin Gu, Ying Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)Andrew B Nixon, Herbert Pang, Mark D Starr, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
American Journal of Epidemiology|November 3, 2016
Direct Participation in and Indirect Exposure to the Occupy Central Movement and Depressive Symptoms: A Longitudinal Study of Hong Kong AdultsMichael Y Ni, Tom K Li, Herbert Pang, et al.
Journal of Hepatology|October 16, 2012
IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patientsMelanie E Garrett, Manal F Abdelmalek, Allison Ashley-Koch, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Genetic predisposition to lung adenocarcinoma among never-smoking Chinese with different epidermal growth factor receptor mutation statusLi Han, Cheuk-Kwong Lee, Herbert Pang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 1, 2012
Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206Michael J Kelley, Jeffrey A Bogart, Lydia D Hodgson, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2020
Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancerXiaowen Cao, Apar Kishor Ganti, Thomas Stinchcombe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 30, 2013
A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904Joseph K Salama, Lydia Hodgson, Herbert Pang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307Sarita Dubey, Pasi A Jänne, Lee Krug, et al.
Molecular Cancer Therapeutics|July 13, 2018
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105Yingmiao Liu, Mark D Starr, John C Brady, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 2015
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groupsXiaofei Wang, Lin Gu, Ying Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)Andrew B Nixon, Herbert Pang, Mark D Starr, et al.
Pageof 11